07 Dec TomoTherapy signs distribution agreements in six new markets
Madison, Wis. – TomoTherapy has announced that it has signed contracts with distributors in Israel, Greece, Poland, Turkey, Russia and the United Arab Emirates to sell and service the TomoTherapy Hi-Art radiation treatment system.
The new distribution agreements extend access to TomoTherapy’s cancer treatment technology to a significant percentage of the global marketplace.
“We are pleased to expand our international presence,” Paul Baumgart, TomoTherapy’s director of international distribution, said in a release. “Until today, our sales efforts have primarily focused on North America, Western Europe, and Asia.”
According to Baumgart, the new distributors have already been in contact with potential customers, and he expects that initial orders could be received within the next few months.
Through the first nine months of 2007, 48 percent of TomoTherapies’ revenue was generated in markets outside the United States. In 2008, the company expects to add even more markets in Central and South America, Australia, New Zealand, Africa, and parts of Eastern Europe.
Since the first cancer patient was treated on a Hi-Art system in July 2003, more than 150 systems have been installed around the world.
• TomoTherapy confirms 59 percent increase in Q3 revenue
• Wisconsin start-up businesses look to UW-Madison office for resources
• TomoTherapy sells first radiation therapy system in China
• TomoTherapy founder says investors should take long view of company performance